Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5547196 | Drug Metabolism and Pharmacokinetics | 2016 | 10 Pages |
Abstract
We conducted a systematic characterization of CYP2C9 variants in 61 Orang Asli and 96 Singaporean Malays using the whole genome sequences data and compared the variants with the other 11 HapMap populations. The frequency of rs1057910 (CYP2C9*3) is the highest in the Orang Asli compared to other populations. Three alleles with clinical implication were detected in the Orang Asli while 2 were found in the Singaporean Malays. Large numbers of the Orang Asli are predicted to have reduced metabolic capacity and therefore they would require a lower dose of drugs which are metabolized by CYP2C9. They are also at increased risks of adverse effects and therapeutic failures. A large number of CYP2C9 variants in the Orang Asli were not in the Hardy Weinberg Equilibrium which could be due to small sample size or mutations that disrupt the equilibrium of allele frequencies. In conclusion, different polymorphism patterns, allele frequencies, genotype frequencies and LD blocks are observed between the Orang Asli, the Singaporean Malays and the other populations. The study provided new information on the genetic polymorphism of CYP2C9 which is important for the implementation of precision medicine for the Orang Asli.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Lay Kek Teh, Vinothini Subramaniam, Tuan Azlin Tuan Abdu Aziz, Lian Shien Lee, Mohamed Izwan Ismail, Choo Yee Yu, Geik Yong Ang, Richard James Johari, Rose Iszati Ismet, Noor Saadah Sahak, Aminuddin Ahmad, Thuhairah Abdul Rahman,